Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Medicare now covers non-invasive peripheral artery disease treatment

Medicare now covers a supervised exercise therapy for peripheral artery disease (PAD), according to CMS, a decision that will likely result in other insurers following this example.

Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2017, which ended April 28, 2017.

West Virginia med school establishes cardiology scholarship

The cardiology department at the Marshall University Joan C. Edwards School of Medicine in Huntington, West Virginia, has created a new endowed scholarship that will help educate students seeking  careers in cardiology, reports the Herald Dispatch.

Thumbnail

AHA awards $2 million to cardiac research at top universities

The American Heart Association (AHA) announced May 19 that it will donate two $1 million research grants to support research on medications and high blood pressure.

ACC president emphasizes access to insurance, quality care in letter to Senate

The repeal-and-replace program for the Affordable Care Act (ACA) has passed through the U.S. House of Representatives, meaning the Senate will soon begin work on comprehensive legislation. Debate remains just how much the Senate will take from the House’s American Health Care Act.

Boston Scientific Announces Agreement to Acquire Symetis

Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire Symetis SA, a privately-held Swiss structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in up-front cash.

Abiomed posts 33 percent increase in revenue as Impella devices gain market momentum

Danvers, Massachusetts-based Abiomed has posted a 33 percent increase in total sales in its fourth quarter, which exceeded market watchers’ expectations, reported The Motley Fool.

Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year

Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2017 revenue of $124.7 million, an increase of 33% compared to revenue of $94.0 million for the same period of fiscal 2016. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.